Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D₃

Table 1

Basic characteristics in the subgroups of patients with deficiency, insufficiency, and normal level of 25-hydroxycholecalciferol.

Parameter	VitDd; n=56; (68%)	VitDi; n=19; (23%)	VitDn; n=7; (9%)	p
Age [years]	43.0 ± 10.1	41.9 ±11.8	43.1 ±11.3	0.94
Sex [% female]	69.6	78.9	85.7	0.54
Height [m]	1.68 ± 0.1	1.68 ± 0.1	1.68 ± 0.08	0.93
Body weight [kg]	68.5 ± 18.3	72.5 ± 15.9	71.6 ± 19.7	0.49
BMI [kg/m^2]	24.3 ± 6.4	25.5 ± 4.5	25.2 ± 5.4	0.31

VitD₃-25-hydroxycholecalciferol, VitDd: vitamin D₃ deficiency, VitDi: vitamin D₃ insufficiency, VitDn: normal vitamin D₃, and BMI: body mass index.